Sponsored Research and Clinical Trial Agreements - Additional Information (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2019 |
|
| Cost of the SRA | $ 300 | $ 300 |
| Research and Development Expense (Excluding Acquired in Process Cost) | 14,867 | 23,273 |
| Cellvation [Member] | ||
| Research and Development Expense (Excluding Acquired in Process Cost) | $ 0 | $ 100 |
| X | ||||||||||
- Definition Represents the cost of the sponsored research arrangement. No definition available.
|
| X | ||||||||||
- Definition The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|